News

“This collaborative effort will help ensure that the application of health AI is based on the best science and is consistent with ethical principles and societal values in pursuit of effectiveness, efficiency, and equity for all members of society.”

A huge climate change victory in Montana.

"...and remember the white and bloodless world I knew before I fell in love."

"With the similarities observed in neurocognitive and neuropsychiatric symptoms of long COVID and concussion/mTBI, approaches to effectively manage concussion/mTBI may provide some insights to treatment."

A phase 2A trial recently received confirmation to proceed in investigating psilocybin-assisted psychotherapy in the treatment of adult patients with IBS.

Are you ready to choose something new?

The meeting will discuss the importance of MOUD in reducing overdose deaths and suicides, improving public health and safety, and aligning with evidence-based practices.

From TMS as a treatment for long COVID to an update on 988 and crisis care, here are highlights from the week in Psychiatric Times.

Psychiatry: a field of medicine that is constantly evolving.

According to recent research, sleep problems were a common symptom in a large study of patients with first-episode psychosis.

This program educated and enlightened attendees on refugees from around the world through song.

What does creativity mean, and what role does it play in medicine, psychiatry, and our lives?

Welcome to Canada!

Investigators also concluded that rTMS may be effective as an adjunctive treatment for patients with MDD.

A psychiatrist discusses his favorite hobby of scuba diving.

"No matter where you are in your career, it is our generation of providers who have the opportunity to facilitate how the medicine of today evolves into the medicine of tomorrow."

Transcranial magnetic stimulation treatment appeared to lessen some neuropsychiatric symptoms of long COVID in an open-label pilot study.

Learn more about a comprehensive system of care for those who are in crisis and need immediate access to care, aided by the new 988 Suicide & Crisis Lifeline.

Fasedienol meets trial endpoints by reducing anxiety during public speaking simulations in patients with social anxiety disorder.

And the winner is…

According to the National Community Pharmacists Association, 97% of independent pharmacy owners reported shortages of Adderall in early 2023. As these shortages continue, here's how you can best support your patients with ADHD.

Emergency department records reveal that youth experiencing disrupted sleep are at greater risk for suicidal thoughts and behaviors.

In need of some late summer reading?

From overutilization of emergency departments to reversible clomiphene-associated manic episodes, here are highlights from the week in Psychiatric Times.

The FDA did not grant approval for the treatment for major depressive disorder.

It all makes sense.

A review of psychiatric referrals and mobile mental health interventions.

“Am I doing the right thing? Is this right for the community I am trying to serve?”

This book could be a resource for your patients with bipolar disorder…

What can we learn from sleep in schizophrenia? New research sheds light.